Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA recommends approval for use of Kineret in adults with COVID-19 16 December 2021NewsHumanCOVID-19 COVID-19: EMA recommends authorisation of antibody medicine Xevudy 16 December 2021NewsHumanCOVID-19Medicines EMA launches the Regulatory Science Research Needs initiative 15 December 2021NewsHumanResearch and development COVID-19 Vaccine Janssen: EMA recommendation on booster dose 15 December 2021NewsHumanCOVID-19Vaccines EMA reviewing new data on effectiveness of Lagevrio (molnupiravir) for the treatment of COVID-19 14 December 2021NewsHumanCOVID-19Medicines International regulators’ reflections on remote approaches to GCP and GMP regulatory oversight during COVID-19 pandemic 13 December 2021NewsHumanCOVID-19 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 December 2021 10 December 2021NewsVeterinaryMaximum residue limitMedicines International regulators stress continued need for COVID-19 therapeutics 10 December 2021NewsHumanCOVID-19Medicines EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: ‘mix-and-match’ approach can be used for both initial courses and boosters 7 December 2021NewsHumanCOVID-19Vaccines ICMRA high-level meeting on global health emergencies and regulatory approaches 6 December 2021NewsHumanCOVID-19MedicinesVaccines 1 … 49 50 51 52 53 Page 53 of 380 54 55 56 57 … 380
COVID-19: EMA recommends authorisation of antibody medicine Xevudy 16 December 2021NewsHumanCOVID-19Medicines
EMA launches the Regulatory Science Research Needs initiative 15 December 2021NewsHumanResearch and development
COVID-19 Vaccine Janssen: EMA recommendation on booster dose 15 December 2021NewsHumanCOVID-19Vaccines
EMA reviewing new data on effectiveness of Lagevrio (molnupiravir) for the treatment of COVID-19 14 December 2021NewsHumanCOVID-19Medicines
International regulators’ reflections on remote approaches to GCP and GMP regulatory oversight during COVID-19 pandemic 13 December 2021NewsHumanCOVID-19
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 December 2021 10 December 2021NewsVeterinaryMaximum residue limitMedicines
International regulators stress continued need for COVID-19 therapeutics 10 December 2021NewsHumanCOVID-19Medicines
EMA and ECDC recommendations on heterologous vaccination courses against COVID-19: ‘mix-and-match’ approach can be used for both initial courses and boosters 7 December 2021NewsHumanCOVID-19Vaccines
ICMRA high-level meeting on global health emergencies and regulatory approaches 6 December 2021NewsHumanCOVID-19MedicinesVaccines